Annals ofMultiple Sclerosis

Volume: 1 - Number: 1 - December 15, 2004

Outstanding

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

Shared scheme for assessing drugs for multiple sclerosis: Cost effective provision of effective treatments for multiple sclerosis

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

Clinical Implications of the Basic Investigation

Molecular Mimicry in Multiple Sclerosis

Editorial

Is Refractory Epilepsy Due to Genetically Determined Resistance to Antiepileptic Drugs?

Integrins as Therapeutic Targets in Autoimmune Disease

Letters to the Editor

Shared scheme for assessing drugs for multiple sclerosis: Cost effective provision of effective treatments for multiple sclerosis

Stress and exacerbations in multiple sclerosis: Authors' reply

Multiple sclerosis

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

Notes

Study suggests hepatitis B vaccine increases risk of multiple sclerosis

Original Articles

Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Perspectives

Do Myelin-Directed Antibodies Predict Multiple Sclerosis?

Review

Mechanisms of Disease: Apoptosis and Caspases in Neurodegenerative Diseases

Medical Progress: Autoimmune Polyendocrine Syndromes

Mechanisms of Disease: Mitochondrial Respiratory-Chain Diseases

Current Concepts: Primary Progressive Aphasia — A Language-Based Dementia

This week in the BMJ

Dronabinol has a modest analgesic effect in multiple sclerosis

Stress may exacerbate multiple sclerosis